World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2023

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 130 2467 2299 118 114 1362 73172

Wolfgang Hiddemann publications per year

The chart shows the history of publications by Wolfgang Hiddemann between 1974 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Wolfgang Hiddemann published across 52 years, from 1974 to 2025, averaging 26.3 papers a year. Output peaked at 89 publications in 2005. 4 of the 1,365 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1974 to 2025. Vertical axis: number of publications, 0 to 89. Peak 89 publications in 2005. 1974: 2 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 1 publication 1979: 1 publication 1980: 0 publications 1981: 2 publications 1982: 3 publications 1983: 0 publications 1984: 3 publications 1985: 13 publications 1986: 9 publications 1987: 10 publications 1988: 3 publications 1989: 10 publications 1990: 25 publications 1991: 3 publications 1992: 17 publications 1993: 10 publications 1994: 25 publications 1995: 26 publications 1996: 24 publications 1997: 63 publications 1998: 42 publications 1999: 34 publications 2000: 26 publications 2001: 58 publications 2002: 36 publications 2003: 51 publications 2004: 81 publications 2005: 89 publications 2006: 58 publications 2007: 53 publications 2008: 47 publications 2009: 50 publications 2010: 24 publications 2011: 35 publications 2012: 38 publications 2013: 30 publications 2014: 52 publications 2015: 33 publications 2016: 73 publications 2017: 71 publications 2018: 49 publications 2019: 27 publications 2020: 19 publications 2021: 23 publications 2022: 5 publications 2023: 7 publications 2024: 1 publication 2025: 3 publications
1974 2025

1,365 publications in total across all disciplines

View publications per year as a table
Wolfgang Hiddemann: publications per year, 1974 to 2025
Year Publications
1974 2
1975 0
1976 0
1977 0
1978 1
1979 1
1980 0
1981 2
1982 3
1983 0
1984 3
1985 13
1986 9
1987 10
1988 3
1989 10
1990 25
1991 3
1992 17
1993 10
1994 25
1995 26
1996 24
1997 63
1998 42
1999 34
2000 26
2001 58
2002 36
2003 51
2004 81
2005 89
2006 58
2007 53
2008 47
2009 50
2010 24
2011 35
2012 38
2013 30
2014 52
2015 33
2016 73
2017 71
2018 49
2019 27
2020 19
2021 23
2022 5
2023 7
2024 1
2025 3
Total 1,365
Download as CSV

Wolfgang Hiddemann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Wolfgang Hiddemann sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,361–1,380 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,362 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28 1,362
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Wolfgang Hiddemann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Wolfgang Hiddemann sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 130–131 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 130 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179 130
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Wolfgang Hiddemann is affiliated with Ludwig-Maximilians-Universität München in Germany and specializes in the field of medicine with a focus on oncology and hematology. Their research covers a range of topics primarily related to cancer, including acute myeloid leukemia (AML), palliative care, end-of-life issues, and cancer survivorship.

They have published extensively in areas such as Oncology, Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, and Genetics. The main research topics associated with their work include:

  • Acute Myeloid Leukemia Research
  • Palliative Care and End-of-Life Issues
  • Histone Deacetylase Inhibitors Research
  • Neutropenia and Cancer Infections
  • Cancer Survivorship and Care
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Aging and Gerontology Research

Wolfgang Hiddemann has contributed to scientific knowledge through various publications. Some notable recent papers include:

  • "Often Relatives are the Key [...]" - Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life, 2020, The Oncologist
  • ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells, 2020, Oncogene
  • Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles, 2023, Communications Medicine
  • Experience of Time and Subjective Age When Facing a Limited Lifetime: The Case of Older Adults with Advanced Cancer, 2021, Journal of Aging and Health
  • Quality of Life and Life Satisfaction in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study, 2021, Blood

Their frequent coauthors contributing to these research activities are Pia Heußner, Karsten Spiekermann, Klaus H. Metzeler, Utz Krug, and Jan Braess.

Wolfgang Hiddemann's work appears prominently in several scientific journals, including:

  • Blood
  • DMW - Deutsche Medizinische Wochenschrift
  • The Oncologist
  • Oncogene
  • Communications Medicine

The scientist's research integrates clinical, genetic, and molecular biology approaches to explore the complexities of hematologic malignancies, with specific attention to patient experience, quality of life, and treatment decision-making in advanced cancer settings.

Best Publications

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

    Wolfgang Hiddemann;Michael Kneba;Martin Dreyling;Norbert Schmitz

  • Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

    Susanne Schnittger;Claudia Schoch;Martin Dugas;Wolfgang Kern

  • Dominant-negative mutations of CEBPA , encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

    Thomas Pabst;Beatrice U. Mueller;Pu Zhang;Hanna S. Radomska

  • A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

    Eva Hoster;Martin Dreyling;Wolfram Klapper;Christian Gisselbrecht

  • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

    Martin Schrappe;Alfred Reiter;Wolf-Dieter Ludwig;Jochen Harbott

  • Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

    Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci

  • Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

    A Reiter;M Schrappe;WD Ludwig;W Hiddemann

  • The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas : results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

    Roswitha Forstpointner;Martin Dreyling;Roland Repp;Sandra Hermann

  • Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

    Georg Lenz;Martin Dreyling;Eva Hoster;Bernhard Wörmann

  • A 17-gene stemness score for rapid determination of risk in acute leukaemia

    Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen

  • Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

    Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof

  • Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

    Rolf D Issels;Lars H Lindner;Jaap Verweij;Peter Wust

  • Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

    Robert Marcus;Andrew Davies;Kiyoshi Ando;Wolfram Klapper

  • Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

    Alessandro Pastore;Vindi Jurinovic;Robert Kridel;Eva Hoster

  • Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG).

    Roswitha Forstpointner;Michael Unterhalt;Martin Dreyling;Hans-Peter Böck

  • Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

    Stephen Johnson;Alister G. Smith;Helmut Löffler

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Convention on nomenclature for DNA cytometry

    Wolfgang Hiddemann;Johannes Schumann;Michael Andreef;Barthel Barlogie

Frequent Co-Authors

Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Claudia Schoch
Claudia Schoch MLL Munich Leukemia Laboratory
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Wolfgang Kern
Wolfgang Kern Munich Leukemia Laboratory (Germany)
Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Stefan K. Bohlander
Stefan K. Bohlander University of Auckland
Achim Heinecke
Achim Heinecke University of Münster
Christian Buske
Christian Buske University of Ulm
Wolfram Klapper
Wolfram Klapper Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education is a popular choice for students pursuing a medical or healthcare career in the USA. If you’re interested in advancing your nursing qualifications, there are flexible online PhD programs in nursing that let you gain research and leadership expertise from home.

For registered nurses looking to expand their credentials affordably, examining the cheapest RN to BSN programs can help you earn your Bachelor of Science in Nursing without breaking the bank.

If you hold a non-nursing bachelor’s degree and want to switch careers, the online direct entry MSN pathway offers a fast track to a master’s degree in nursing—even if you haven’t worked in the field before.

Entry requirements can feel daunting, but there are resources to help find what is the easiest nursing program to get into. This guidance can make launching your healthcare career more accessible.

Best Scientists Citing Wolfgang Hiddemann

Trending Scientists

Recently Published Articles